Personal information

Biography

Acquisition of theoretical and technical knowledge on the field of application of molecular biology, human genetics and pharmacology to the study of pharmacogenetics/ pharmacogenomics of anti-cancer drugs. Collaboration in the design and management of clinical trials focused to pharmacogenetics/genomics markers discovery and validation. Very good knowledge of semi-automated PCR based genotyping methods (i.e. Pyrosequencing, allelic discrimination-TaqMan technology, fragment analysis) as well as of the novel high-throughput Next-generation sequencing (NGS) Technologies (i.e. Illumina – Miseq). Acquisition of theoretical and methodological knowledge on the field of emerging technologies for clinically relevant sequence-based analysis of cfDNA in cancer patients.

Activities

Employment (3)

Centro di Riferimento Oncologico di Aviano (CRO) IRCCS: Aviano, Friuli-Venezia Giulia, IT

2012-04-01 to present | Researcher, Ph.D. (Contrattista Junior) (Experimental and Clinical Pharmacology Unit - Department of Translational research)
Employment
Source: Self-asserted source
Elena De Mattia

Centro di Riferimento Oncologico di Aviano (CRO) IRCCS: Aviano, Friuli-Venezia Giulia, IT

2010-04-01 to 2012-03-31 | Research Fellowship (Borsa di studio, second level) ( Experimental and Clinical Pharmacology Unit - Department of Translational research)
Employment
Source: Self-asserted source
Elena De Mattia

Centro di Riferimento Oncologico di Aviano (CRO) IRCCS: Aviano, Friuli-Venezia Giulia, IT

2007-01-02 to 2010-02-28 | Research Fellowship (Borsa di studio, first level) ( Experimental and Clinical Pharmacology Unit - Department of Translational research)
Employment
Source: Self-asserted source
Elena De Mattia

Education and qualifications (4)

Università degli Studi di Parma: Parma, Emilia-Romagna, IT

2015-06 to present | Authorization to practice the BIOLOGIST profession with the passing of the State Exam in June 2015 (score 200/200).
Qualification
Source: Self-asserted source
Elena De Mattia

Università degli Studi di Padova: Padova, Veneto, IT

2008-01-01 to 2010-12-31 | Ph. D. in Pharmacological Sciences, Molecular and Cellular Pharmacology (Università degli Studi di Padova - Dipartimento di Farmacologia ed Anestesiologia “Egidio Meneghetti”)
Education
Source: Self-asserted source
Elena De Mattia

Università degli Studi di Trieste: Trieste, Friuli-Venezia Giulia, IT

2003-09 to 2006-04 | Laurea Degree in Medical Biotechnology (Magistrale Degree), Result : 110/110, with honors (Facoltà di Medicina e Chirurgia)
Education
Source: Self-asserted source
Elena De Mattia

Università degli Studi di Trieste: Trieste, Friuli-Venezia Giulia, IT

2000-09 to 2003-07 | Laurea Degree in Medical Biotechnology (Triennale Degree), Result : 110/110, with honors (Facoltà di Medicina e Chirurgia)
Education
Source: Self-asserted source
Elena De Mattia

Funding (1)

Application of GLIADEL wafers (BCNU, carmustine) followed by temozolomide and radiotherapy in patients with high-grade glioma: a precision medicine based on molecular landscape

2019 to 2021 | Grant
Ministero della Salute (Roma, IT)
GRANT_NUMBER:

GR-2016-02364678

Source: Self-asserted source
Elena De Mattia

Peer review (42 reviews for 15 publications/grants)

Review activity for All Life (3)
Review activity for British journal of cancer. (9)
Review activity for Cancers. (6)
Review activity for Expert opinion on drug metabolism and toxicology (1)
Review activity for Frontiers in immunology. (1)
Review activity for Frontiers in oncology. (1)
Review activity for Frontiers in pharmacology. (4)
Review activity for Genes. (1)
Review activity for Pharmaceutics. (3)
Review activity for Pharmacogenomics and personalized medicine (1)
Review activity for PloS one. (2)
Review activity for Targeted oncology. (1)
Review activity for Targeted oncology. (1)
Review activity for The pharmacogenomics journal. (6)
Review activity for Therapeutic advances in medical oncology. (2)